Transplantation across previously incompatible immunological barriers

Transplant International

Volumn 19, Issue 2, 2006, Pages 87-97

  Magee, Colm C ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Crossmatch; Desensitization; Incompatibility; Rejection; Transplantation

Indexed keywords

BASILIXIMAB; DACLIZUMAB; HLA ANTIBODY; IMMUNOGLOBULIN G; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE;

ANAPHYLAXIS; ANTIBODY RESPONSE; BLOOD GROUP ABO INCOMPATIBILITY; CENTRAL RETINA VEIN OCCLUSION; CHILL; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DESENSITIZATION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOPLASMOSIS; HUMAN; IMMUNOADSORPTION; IMMUNOMODULATION; KIDNEY DONOR; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY VEIN THROMBOSIS; LIVER TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; NEPHROTOXICITY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SPLENECTOMY; THROMBOSIS;

ABO BLOOD-GROUP SYSTEM; ANTIBODIES, MONOCLONAL; CLINICAL PROTOCOLS; DESENSITIZATION, IMMUNOLOGIC; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; LIVING DONORS; PLASMAPHERESIS; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY;

EID: 33645328049     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2005.00257.x     Document Type: Review

References (35)

1. Fuggle SV Martin S Toward performing transplantation in highly sensitized patients Transplantation 2004 78 186
2. Mahoney RJ Taranto S Edwards E B-Cell crossmatching and kidney allograft outcome in 9031 United States transplant recipients Hum Immunol 2002 63 324
3. Jordan S Cunningham-Rundles C McEwan R Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications Am J Transplant 2003 3 653
4. Clark B Cole JY Wortley A et al. Intravenous immunoglobulin-induced panel reactive antibody A reduction: not all preparations are created equal Transplantation 2003 75 242
5. Glotz D Antoine C Julia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg) Am J Transplant 2002 2 758
6. Jordan SC Vo A Bunnapradist S et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients Transplantation 2003 76 631
7. Jordan SC Tyan D Stablein D et al. Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial J Am Soc Nephrol 2004 15 3256
8. Gloor JM DeGoey SR Pineda AA et al. Overcoming a positive crossmatch in living-donor kidney transplantation Am J Transplant 2003 3 1017
9. Montgomery RA Zachary AA Racusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 2000 70 887
10. Schweitzer EJ Wilson JS Fernandez-Vina M et al. A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants Transplantation 2000 70 1531
11. Montgomery RA Zachary AA Transplanting patients with a positive donor-specific crossmatch: a single center's perspective Pediatr Transplant 2004 8 535
12. Lorenz M Regele H Schillinger M et al. Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch-positive cadaveric kidney allograft recipients Transplantation 2005 79 696
13. Olausson M Mjornstedt L Norden G et al. Auxiliary liver and combined kidney transplantation prevents hyperacute kidney rejection in highly sensitized patients Transplant Proc 2002 34 3106
14. Tinckam KJ Wood IG Ji F Milford EL ATG induction is associated with an increase in anti-HLA antibodies after kidney transplantation Hum Immunol 2004 65 1281
15. Vieira CA Agarwal A Book BK et al. Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics Transplantation 2004 77 542
16. Terasaki PI Ozawa M Predicting kidney graft failure by HLA antibodies: a prospective trial Am J Transplant 2004 4 438
17. Zachary AA Montgomery RA Ratner LE et al. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients Transplantation 2003 76 1519
18. Gloor JM DeGoey S Ploeger N et al. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation Transplantation 2004 78 221
19. Zachary AA Montgomery RA Leffell MS Factors associated with and predictive of persistence of donor-specific antibody after treatment with plasmapheresis and intravenous immunoglobulin Hum Immunol 2005 66 364
20. Claas FH Witvliet MD Duquesnoy RJ Persijn GG Doxiadis II The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome Transplantation 2004 78 190
21. de Klerk M Keizer KM Claas FH Witvliet M Haase-Kromwijk BJ Weimar W The Dutch national living donor kidney exchange program Am J Transplant 2005 5 2302
22. Kaplan I Houp JA Leffell MS Hart JM Zachary AA A computer match program for paired and unconventional kidney exchanges Am J Transplant 2005 5 2306
23. Segev DL Gentry SE Warren DS Reeb B Montgomery RA Kidney paired donation and optimizing the use of live donor organs Jama 2005 293 1883
24. Gentry SE Segev DL Montgomery RA A comparison of populations served by kidney paired donation and list paired donation Am J Transplant 2005 5 1914
25. Ross LF Zenios S Practical and ethical challenges to paired exchange programs Am J Transplant 2004 4 1553
26. Delmonico FL Morrissey PE Lipkowitz GS et al. Donor kidney exchanges Am J Transplant 2004 4 1628
27. Takahashi K Saito K Takahara S et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan Am J Transplant 2004 4 1089
28. Gloor JM Lager DJ Moore SB et al. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors Transplantation 2003 75 971
29. Sonnenday CJ Warren DS Cooper M et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD20 allow ABO-incompatible renal transplantation without splenectomy Am J Transplant 2004 4 1315
30. Stegall MD Dean PG Gloor JM ABO-incompatible kidney transplantation Transplantation 2004 78 635
31. Tyden G Kumlien G Genberg H Sandberg J Lundgren T Fehrman I ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab Am J Transplant 2005 5 145
32. Rydberg L Bengtsson A Samuelsson O Nilsson K Breimer ME In vitro assessment of a new ABO immunosorbent with synthetic carbohydrates attached to sepharose Transpl Int 2005 17 666
33. Nelson PW Shield III CF. Muruve NA et al. Increased access to transplantation for blood group B cadaveric waiting list candidates by using A2 kidneys: time for a new national system Am J Transplant 2002 2 94
34. Ishida H Tanabe K Ishizuka T et al. The mechanism responsible for accommodation after living-related kidney transplantations across the blood barrier Transpl Int 2005 18 716
35. Warren DS Zachary AA Sonnenday CJ et al. Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers Am J Transplant 2004 4 561